Journal of International Oncology ›› 2013, Vol. 40 ›› Issue (6): 409-412.

Previous Articles     Next Articles

Targeting regulatory T cells and immunotherapy of tumor

ZHAO  Gang, SU  Qing, LI  Jing, LIU  Ai-Qin   

  1. Institute of Materia Medica, Shandong Academy of Medical Scince, Jinan 250062, China
  • Online:2013-06-08 Published:2013-05-24
  • Contact: LIU Ai-qin E-mail:liuaiqin6@126.com

Abstract: Regulatory T cells (Tregs) possess the function of immune suppression and achieve immunosuppression by the approach of expressing cytotoxic T lymphocyte-associated antigen, perforin-particle enzyme mediated cytotoxic effect, and secretion of cytokines such as IL-10, TGF-β, et al. The antibodies, vaccines and chemical drugs can be applied for targeting FOXP3+CD25+CD4+Tregs, depleting Tregs in peripheral blood and tumor tissues of patients of various forms of cancers. The function of immune suppression can be decreased and antitumor curative effects by immunotherapy can be enhanced.

Key words: Neoplasmas, T-lymphocytes cells, regulatory, Immunotherapy